Trade Alert – Equity & ETF Model
This morning, we reduced Costco (COST) by 1% and the iShares Staples ETF (XLP) by 2%. This morning’s Commentary started with a piece on the new obesity drug Ozempic. As we wrote:
“Unfortunately for Coke, Pepsi, Mcdonald’s, and other companies, users claim they eat less food. Walmart confirmed initial reactions, saying its customers taking Ozempic and other appetite-suppressing drugs are purchasing less food.“
COST shares have started slipping with other food purveyors as investors worry about the effect of the obesity drugs on their sales. Whether the drugs will meaningfully affect sales or not, the market seems bent on pricing with negative consequences.
We have owned COST shares for a long time, and this reduction in weighting is temporary until the market figures out the implications of these drugs. We are already looking to increase our weighting in COST in the future.
Equity Model
- Reduce COST to 2% of the Portfolio.
ETF Model
- Reduce XLP from 9% to 7% of the Portfolio
Want These Alerts Via TEXT?
To receive trade information via text, click on your user name in the upper right corner of the website. Then click My Account and the title SMS Notification Preferences.
NOTE: You must add your country code in front of your number. The U.S. code is 1.
Please let us know if you have any problems.
Lance Roberts is a Chief Portfolio Strategist/Economist for RIA Advisors. He is also the host of “The Lance Roberts Podcast” and Chief Editor of the “Real Investment Advice” website and author of “Real Investment Daily” blog and “Real Investment Report“. Follow Lance on Facebook, Twitter, Linked-In and YouTube
Customer Relationship Summary (Form CRS)